Jones Financial Companies
MGNX icon

Jones Financial Companies’s MacroGenics MGNX Stock Holding History

Jones Financial Companies’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144 Hold
30
– – ﹤0.01% 4870
2026
Q1 		$88 Hold
30
– – ﹤0.01% 4646
2025
Q4 		$48 Hold
30
– – ﹤0.01% 4342
2025
Q3 		$52 Hold
30
– – ﹤0.01% 4180
2025
Q2 		$36 Hold
30
– – ﹤0.01% 3982
2025
Q1 		$38 Hold
30
– – ﹤0.01% 3664
2024
Q4 		$98 Buy
+30
New +$108 ﹤0.01% 3354

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jones Financial Companies's MGNX Position: Q2 2026 in Review

Jones Financial Companies held its MacroGenics (MGNX) position steady in Q2 2026 at 30 shares worth $144. The position accounts for ﹤0.01% of the portfolio, ranked #4870.

Jones Financial Companies first reported a position in MGNX in Q4 2024 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Jones Financial Companies held 30 shares of MacroGenics worth $144 as of Q2 2026.
  • Jones Financial Companies left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4870 holding.
  • Jones Financial Companies first reported a position in MacroGenics in Q4 2024 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.